1. Home
  2. SQNS vs KPTI Comparison

SQNS vs KPTI Comparison

Compare SQNS & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$2.87

Market Cap

46.9M

Sector

Technology

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$1.99

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
KPTI
Founded
2003
2008
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.9M
47.6M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
SQNS
KPTI
Price
$2.87
$1.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$20.33
$16.00
AVG Volume (30 Days)
66.3K
2.2M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$49.79
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.57
52 Week Low
$0.73
$1.80
52 Week High
$10.93
$10.99

Technical Indicators

Market Signals
Indicator
SQNS
KPTI
Relative Strength Index (RSI) 53.97 18.44
Support Level $2.86 N/A
Resistance Level $3.27 $9.45
Average True Range (ATR) 0.19 0.35
MACD 0.06 -0.18
Stochastic Oscillator 63.64 3.15

Price Performance

Historical Comparison
SQNS
KPTI

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: